Brent Furse
Chief Executive Officer at Vero Biotech LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Todd Brady | M | 45 |
Vero Biotech, Inc.
Vero Biotech LLC
 Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | 9 years |
| Daniel Salazar | M | - |
Vero Biotech, Inc.
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | - |
| Patrick P. Lally | M | - |
Vero Biotech, Inc.
| - |
| David Stocker | M | - |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | 8 years |
| Ganesh Raghu | M | - |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Glenn Sblendorio | M | 68 | 16 years | |
| David Stack | M | 72 | 3 years | |
| Fred M. Ryan | M | 72 | 5 years | |
| Dennis P. Reilly | M | 65 | 3 years | |
| John Whiting | M | 63 |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | 5 years |
| William W. Crouse | M | 80 | 15 years | |
| Robert Hugin | M | 69 | 15 years | |
| Melvin Spigelman | M | 75 | 13 years | |
| Bill O'Connor | M | 64 | 12 years | |
| Hiroaki Shigeta | M | 81 | - | |
| Paul Antinori | M | 70 | 12 years | |
| John Kelley | M | 70 | 5 years | |
| Robert G. Savage | M | 70 | 13 years | |
| Elizabeth Hamilton Seabury Wyatt | M | 76 | - | |
| Steven Hubrig Koehler | M | 73 | 4 years | |
| Gregory C. Williams | M | 65 | 7 years | |
| Gregory Fiore | M | 54 | - | |
| Christopher Visioli | M | 48 | 17 years | |
| Brian Leuthner | M | 59 | 2 years | |
| Farzad Parsaie | M | 64 |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | 3 years |
| Rob Mitchell | M | - | 4 years | |
| Doug Randall | M | - | 5 years | |
| David Carroll | M | 58 | 8 years | |
| Marianne Andreach | F | - | - | |
| Douglas Kling | M | 50 | 1 years | |
| E. Blair Clark-Schoeb | F | - | 2 years | |
| Robert J. Weiland | M | 64 | 2 years | |
| Cornelis J. Heiman | M | - | - | |
| David Hanley | M | 54 | 3 years | |
| Michael McGuire | M | - | - | |
| Marc Morin | M | - |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | 4 years |
| Namita Khanna | F | - |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | 5 years |
| Jason White | M | - |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | - |
| Darryl Wellinghoff | M | 55 | 15 years | |
| Anthony Flammia | M | - | - | |
| Fazle Husain | M | 60 | 5 years | |
| Siegfried S. Rogy | M | - | 2 years | |
| Eric Loumeau | M | 61 | 2 years | |
| Gary Roubin | M | 75 | 1 years | |
| Catharine S. Newberry | F | 73 | 3 years | |
| Jennifer Foley | F | - | 2 years | |
| Kelli Watson-Pacicco | F | 62 | - | |
| Leslie C. Rohrbacker | F | 55 | 7 years | |
| Leonard Bell | M | 65 | 5 years | |
| James Edward Thomas | M | 63 | 9 years | |
| Robert Yedid | M | 66 | 2 years | |
| Michael Mitchell | M | - | - | |
| Eric Finkelman | M | - |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | - |
| Peter Teuber | M | - | - | |
| Sanuj K. Ravindran | M | - | - | |
| Matthew Wikler | M | 74 | 3 years | |
| Robert B. Pelletier | M | 71 | 3 years | |
| Gary Dickinson | M | 72 | - | |
| Loretta Itri | M | 74 | 6 years | |
| Lance Baldo | M | 51 | 5 years | |
| James Ferguson | M | 70 | 2 years | |
| Ali Behbahani | M | 45 | 2 years | |
| Erica Bitten | F | - |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 63 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Brent Furse
- Personal Network
